Linezolid‐resistant S. epidermidis clone ST‐2 isolated from a patient who did not receive any course of oxazolidinone therapy: a case report

References

1. Almeida L.M., Lincopan N., Araújo M.R., Mamizuka E.M. ( 2012). Dissemination of the linezolid‐resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary‐care hospital, Brazil. J Antimicrob Chemother 67:768–769 [CrossRef]
   [Google Scholar]
2. CLSI( 2013). Performance Standards for Antimicrobial Susceptibility Testing; 23rd informational supplement, CLSI M100‐S23 Wayne, PA: Clinical and Laboratory Standards Institute;
   [Google Scholar]
3. Hirotaki S., Sasaki T., Kuwahara‐Arai K., Hiramatsu K. ( 2011). Rapid and accurate identification of human‐associated staphylococci by use of multiplex PCR. J Clin Microbiol 49:3627–3631 [CrossRef]
   [Google Scholar]
4. Ikeda‐Dantsuji Y., Hanaki H., Sakai F., Tomono K., Takesue Y., Honda J., Nonomiya Y., Suwabe A., Nagura O. other authors( 2011). Linezolid‐resistant Staphylococcus aureus isolated from 2006 through 2008 at six hospitals in Japan. J Infect Chemother 17:45–51 [CrossRef]
   [Google Scholar]
5. Jones R.N., Della‐Lattac P., Leec L.V., Biedenbach D.J. ( 2002). Linezolid‐resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 42:137–139 [CrossRef]
   [Google Scholar]
6. Kehrenberg C., Schwarz S. ( 2006). Distribution of florfenicol resistance genes fexA and cfr among chloramphenicol‐resistant Staphylococcus isolates. Antimicrob Agents Chemother 50:1156–1163 [CrossRef]
   [Google Scholar]
7. Liakopoulos A., Neocleous C., Klapsa D., Kanellopoulou M., Spiliopoulou I., Mathiopoulos K.D., Papafrangas E., Petinaki E. ( 2009a). A T2504A mutation in the 23S rRNA gene responsible for high‐level resistance to linezolid of Staphylococcus epidermidis . J Antimicrob Chemother 64:206–207 [CrossRef]
   [Google Scholar]
8. Liakopoulos A., Spiliopoulou I., Damani A., Kanellopoulou M., Schoina S., Papafragas E., Marangos M., Fligou F., Zakynthinos E. other authors( 2010b). Dissemination of two international linezolid‐resistant Staphylococcus epidermidis clones in Greek hospitals. J Antimicrob Chemother 65:1070–1071 [CrossRef]
   [Google Scholar]
9. Mendes R.E., Deshpande L.M., Farrell D.J., Spanu T., Fadda G., Jones R.N. ( 2010). Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. J Antimicrob Chemother 65:2329–2335 [CrossRef]
   [Google Scholar]
10. Miller K., Dunsmore C.J., Fishwick C.W., Chopra I. ( 2008). Linezolid and tiamulin cross‐resistance in Staphylococcus aureus mediated by point mutations in the peptidyl transferase center. Antimicrob Agents Chemother 52:1737–1742 [CrossRef]
    [Google Scholar]
11. Wong A., Reddy S.P., Smyth D.S., Aguero‐Rosenfeld M.E., Sakoulas G., Robinson D.A. ( 2010). Polyphyletic Emergence of Linezolid‐Resistant Staphylococci in the United States. Antimicrob Agents Chemother 54:742–748 [CrossRef]
    [Google Scholar]